↓ Skip to main content

Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial

Overview of attention for article published in Endocrine, June 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
52 Mendeley
Title
Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial
Published in
Endocrine, June 2017
DOI 10.1007/s12020-017-1316-3
Pubmed ID
Authors

S. Petersenn, L. R. Salgado, J. Schopohl, L. Portocarrero-Ortiz, G. Arnaldi, A. Lacroix, C. Scaroni, S. Ravichandran, A. Kandra, B. M. K. Biller

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 12%
Researcher 5 10%
Student > Doctoral Student 5 10%
Student > Bachelor 5 10%
Student > Postgraduate 4 8%
Other 10 19%
Unknown 17 33%
Readers by discipline Count As %
Medicine and Dentistry 22 42%
Nursing and Health Professions 4 8%
Agricultural and Biological Sciences 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Immunology and Microbiology 1 2%
Other 1 2%
Unknown 20 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2024.
All research outputs
#3,392,835
of 25,661,882 outputs
Outputs from Endocrine
#190
of 1,949 outputs
Outputs of similar age
#59,065
of 332,185 outputs
Outputs of similar age from Endocrine
#1
of 24 outputs
Altmetric has tracked 25,661,882 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,949 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 332,185 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.